Candidate tumor-specific CD8 <sup>+</sup> T cell subsets identified in the malignant pleural effusion of advanced lung cancer patients by single-cell analysis
Yusuke Sugita(Aichi Cancer Center), Hirokazu Matsushita(Aichi Cancer Center), Kana Hashimoto(Tokyo Metropolitan Komagome Hospital), Hiroshi Hamana(University of Toyama), Eiichi Sasaki(Aichi Cancer Center), Daiki Miura(NEC (Japan)), Chieko Takashima(Aichi Cancer Center), Teppei Yamaguchi(Aichi Cancer Center), Hiroyuki Kishi(University of Toyama), Yoshitsugu Horio(Aichi Cancer Center), Reina Nishida(Aichi Cancer Center), Yuki Tanaka(NEC (Japan)), Kazuhide Onoguchi(NEC (Japan)), Yusuke Takahashi(Jikei University School of Medicine), Takuya Matsui(Aichi Cancer Center), Katsuhiro Masago(Aichi Cancer Center), Hiroaki Kuroda(Aichi Cancer Center), Hiroyasu Komuro(Aichi Cancer Center), Daisuke Muraoka(University of Shizuoka), Rui Yamaguchi, Trevor Clancy(Inholland University of Applied Sciences), Richard Stratford, Kousuke Onoue(NEC (Japan)), Kenichi Okubo(Tokyo Medical and Dental University), Hironori Ishibashi(Tokyo Medical and Dental University), Yoshiko Yamashita(NEC (Japan)), Shuichi Shinohara(Aichi Cancer Center), Ichidai Tanaka(Nagoya University), Yasunori Fukushima(Aichi Cancer Center), Ayako Demachi‐Okamura(Aichi Cancer Center)
Cited by 9
Related Papers
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
|Clinical Cancer Research|2018|195
Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase
|The Journal of Cell Biology|2010|165
Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance
|Journal of Clinical Investigation|2019|143
Remodeling of secretory lysosomes during education tunes functional potential in NK cells
|Nature Communications|2019|129